Wenbin Hou

599 total citations
40 papers, 398 citations indexed

About

Wenbin Hou is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Wenbin Hou has authored 40 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 10 papers in Pulmonary and Respiratory Medicine and 9 papers in Cancer Research. Recurrent topics in Wenbin Hou's work include Gastric Cancer Management and Outcomes (5 papers), Metastasis and carcinoma case studies (5 papers) and Renal cell carcinoma treatment (4 papers). Wenbin Hou is often cited by papers focused on Gastric Cancer Management and Outcomes (5 papers), Metastasis and carcinoma case studies (5 papers) and Renal cell carcinoma treatment (4 papers). Wenbin Hou collaborates with scholars based in China and Japan. Wenbin Hou's co-authors include Huimian Xu, Songcheng Yin, Jinyu Huang, Wenfeng Gou, Yuen Tan, Pengliang Wang, Ying‐Jie Chen, Deqiang Dou, Huiqiang Wei and Yingying Xu and has published in prestigious journals such as Journal of Medicinal Chemistry, Frontiers in Immunology and Cancer Letters.

In The Last Decade

Wenbin Hou

38 papers receiving 391 citations

Peers

Wenbin Hou
Yao Sun China
Yujie Lu China
Arti Verma United States
Yuan Dong China
Dejun Cui China
Yu Yin China
Wenbin Hou
Citations per year, relative to Wenbin Hou Wenbin Hou (= 1×) peers Jinghui Zheng

Countries citing papers authored by Wenbin Hou

Since Specialization
Citations

This map shows the geographic impact of Wenbin Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenbin Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenbin Hou more than expected).

Fields of papers citing papers by Wenbin Hou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenbin Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenbin Hou. The network helps show where Wenbin Hou may publish in the future.

Co-authorship network of co-authors of Wenbin Hou

This figure shows the co-authorship network connecting the top 25 collaborators of Wenbin Hou. A scholar is included among the top collaborators of Wenbin Hou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenbin Hou. Wenbin Hou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Gou, Wenfeng, et al.. (2025). Target Discovery Driven by Chemical Biology and Computational Biology. The Chemical Record. 25(3). e202400182–e202400182.
3.
Gou, Wenfeng, et al.. (2024). Mass spectrometry imaging for unearthing and validating quality markers in traditional Chinese medicines. Chinese Herbal Medicines. 17(1). 31–40. 2 indexed citations
4.
Gou, Wenfeng, Feifei Xu, Yue Hou, et al.. (2024). Protective effect of Camellia nitidissima Chi on γ rays radiation-induced hematopoietic and gastrointestinal damage. 4(4). 487–499. 1 indexed citations
5.
Liu, Weiyang, et al.. (2024). Hexokinase HK3-mediated O-GlcNAcylation of EP300: a key regulator of PD-L1 expression and immune evasion in ccRCC. Cell Death and Disease. 15(8). 613–613. 3 indexed citations
6.
Dai, Dong, Wenfeng Gou, Yanli Li, et al.. (2024). Novel CDK19-Targeted Radiotracers: A Potential Design Strategy to Improve the Pharmacokinetics and Tumor Uptake. Journal of Medicinal Chemistry. 67(8). 6726–6737. 3 indexed citations
7.
Liu, Weiyang, Wei Zhang, Zhuolun Li, et al.. (2023). The categorizations of vasculogenic mimicry in clear cell renal cell carcinoma unveil inherent connections with clinical and immune features. Frontiers in Pharmacology. 14. 1333507–1333507. 2 indexed citations
8.
Li, Xuedong, et al.. (2022). Identification of a Five-miRNA Signature for Diagnosis of Kidney Renal Clear Cell Carcinoma. Frontiers in Genetics. 13. 857411–857411. 4 indexed citations
9.
Gou, Wenfeng, Xiaojun Yu, Shao‐Hua Wu, et al.. (2022). Targeted inhibition of acidic nucleoplasmic DNA-binding protein 1 enhances radiosensitivity of non-small cell lung cancer. Cancer Letters. 530. 100–109. 12 indexed citations
10.
Gou, Wenfeng, et al.. (2022). Discovery of the radio-protecting effect of Ecliptae Herba, its constituents and targeting p53-mediated apoptosis in vitro and in vivo. Acta Pharmaceutica Sinica B. 13(3). 1216–1230. 16 indexed citations
11.
Gou, Wenfeng, Na Luo, Hongying Wu, et al.. (2022). Ursolic Acid Derivative UA232 Promotes Tumor Cell Apoptosis by Inducing Endoplasmic Reticulum Stress and Lysosomal Dysfunction. International Journal of Biological Sciences. 18(6). 2639–2651. 18 indexed citations
12.
Gou, Wenfeng, et al.. (2022). Molecular mechanisms of isoflavone puerarin against cardiovascular diseases: What we know and where we go. Chinese Herbal Medicines. 14(2). 234–243. 27 indexed citations
13.
14.
Ma, Yanan, et al.. (2021). Identification of Immune-Related lncRNA Prognostic Signature and Molecular Subtypes for Glioblastoma. Frontiers in Immunology. 12. 706936–706936. 38 indexed citations
15.
Wei, Huiqiang, Jingcheng Yu, Wenfeng Gou, et al.. (2021). Discovery of novel triazole compounds as selective IL-1β releasement inhibitors. Bioorganic & Medicinal Chemistry Letters. 53. 128415–128415. 4 indexed citations
16.
Liao, Xing, et al.. (2021). An evidence mapping of systematic reviews and meta-analysis on traditional Chinese medicine for ulcerative colitis. BMC Complementary Medicine and Therapies. 21(1). 228–228. 9 indexed citations
17.
Huang, Jinyu, Weilan Zhang, Yanan Xing, et al.. (2020). Increased Expression of LIPC Is Associated with Aggressive Phenotype of Borrmann Type 4 Gastric Cancer. Journal of Gastrointestinal Surgery. 25(4). 900–910. 4 indexed citations
18.
Tan, Yuen, Pengliang Wang, Songcheng Yin, et al.. (2019). Thirty-year trends in clinicopathologic characteristics and prognosis after gastrectomy for gastric cancer: A single institution in Northern China. Journal of Cancer. 11(5). 1056–1062. 17 indexed citations
19.
Huang, Jinyu, Yanan Xing, Xin Wang, et al.. (2019). The Prognosis Value of Lymphatic Vessel Invasion in pN0 Gastric Cancer Patients with Insufficient Examined Lymph Nodes. Journal of Gastrointestinal Surgery. 24(2). 299–306. 5 indexed citations
20.
Huang, Jinyu, et al.. (2018). Should All Stage N3b Patients with Advanced Gastric Cancer Be Considered Equivalent? A 30-Year Single Center Study. Journal of Gastrointestinal Surgery. 23(9). 1742–1747. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026